Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma
an in vitro approach
DOI:
https://doi.org/10.51126/revsalus.v4iSup.401Keywords:
renal cell carcinoma, tyrosine kinase inhibitors, antiproliferative, cytotoxicity, in vitroDownloads
Download data is not yet available.
Downloads
Published
2022-04-06
Conference Proceedings Volume
Section
Posters
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma: an in vitro approach. (2022). RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone, 4(Sup), 167-168. https://doi.org/10.51126/revsalus.v4iSup.401







